A Phase I Study of Various Administration Schedules of RO4929097 With Multi-parameter Assessment (Biomarkers, Pharmacokinetics, Pharmacodynamics) in Patients With Advanced Solid Cancers.
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2014
At a glance
- Drugs RG 4733 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 01 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.